Full text

Turn on search term navigation

© 2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

The addition of radiation therapy to chemotherapy and impact on outcomes in primary bone lymphoma is not clear. Nonetheless, tumor location must be considered as radiation to marrow‐rich bone areas can lead to myelosuppression and myelotoxicity.

Details

Title
Primary bone lymphoma of the ilium successfully treated without radiation
Author
Nguyen, Charles B 1   VIAFID ORCID Logo  ; Li, Monica 2 ; Verstovsek, Gordana 3 ; Sen, Urmi 4 ; Swierenga, Christi 5 ; Huang, Quillan 6 ; Rivero, Gustavo 6 ; Yellapragada, Sarvari V 6 

 Department of Medicine, Baylor College of Medicine, Houston, TX, USA 
 Baylor College of Medicine, Houston, TX, USA 
 Michael E. DeBakey VA Medical Center, Houston, TX, USA; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA 
 Michael E. DeBakey VA Medical Center, Houston, TX, USA; Department of Radiology, Baylor College of Medicine, Houston, TX, USA 
 Michael E. DeBakey VA Medical Center, Houston, TX, USA 
 Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Michael E. DeBakey VA Medical Center, Houston, TX, USA; Section of Hematology & Oncology, Baylor College of Medicine, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA 
Pages
3129-3132
Section
CASE REPORTS
Publication year
2020
Publication date
Dec 2020
Publisher
John Wiley & Sons, Inc.
e-ISSN
20500904
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2557164571
Copyright
© 2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.